• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致肝硬化患者发生显性肝性脑病的因素。

Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.

作者信息

Iwasa Motoh, Sugimoto Ryosuke, Mifuji-Moroka Rumi, Hara Nagisa, Yoshikawa Kyoko, Tanaka Hideaki, Eguchi Akiko, Yamamoto Norihiko, Sugimoto Kazushi, Kobayashi Yoshinao, Hasegawa Hiroshi, Takei Yoshiyuki

机构信息

Department of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu, Mie, 514-8507, Japan.

Nutrition Unit, Mie University Hospital, Tsu, Japan.

出版信息

Metab Brain Dis. 2016 Oct;31(5):1151-6. doi: 10.1007/s11011-016-9862-6. Epub 2016 Jun 29.

DOI:10.1007/s11011-016-9862-6
PMID:27353278
Abstract

The aim of this study was to clarify the relationships among psychometric testing results, blood ammonia (NH3) levels, electrolyte abnormalities, and degree of inflammation, and their associations with the development of overt hepatic encephalopathy (HE) in liver cirrhosis (LC) patients. The relationships between covert HE and blood NH3, sodium (Na), and C-reactive protein (CRP) were examined in 40 LC patients. The effects of elevated NH3, hyponatremia, and elevated CRP on the development of overt HE were also investigated. The covert HE group had significantly lower serum Na levels and significantly higher serum CRP levels. During the median observation period of 11 months, 10 patients developed overt HE, and the results of multivariate analysis showed that covert HE and elevated blood NH3 were factors contributing to the development of overt HE. Electrolyte abnormalities and mild inflammation are involved in the pathogenesis of HE. Abnormal psychometric testing results and hyperammonemia are linked to subsequent development of overt HE.

摘要

本研究的目的是阐明心理测量测试结果、血氨(NH₃)水平、电解质异常和炎症程度之间的关系,以及它们与肝硬化(LC)患者显性肝性脑病(HE)发生的关联。在40例LC患者中,研究了隐匿性HE与血NH₃、钠(Na)和C反应蛋白(CRP)之间的关系。还研究了NH₃升高、低钠血症和CRP升高对显性HE发生的影响。隐匿性HE组的血清Na水平显著降低,血清CRP水平显著升高。在11个月的中位观察期内,10例患者发生了显性HE,多变量分析结果显示,隐匿性HE和血NH₃升高是导致显性HE发生的因素。电解质异常和轻度炎症参与了HE的发病机制。心理测量测试结果异常和高氨血症与随后显性HE的发生有关。

相似文献

1
Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.导致肝硬化患者发生显性肝性脑病的因素。
Metab Brain Dis. 2016 Oct;31(5):1151-6. doi: 10.1007/s11011-016-9862-6. Epub 2016 Jun 29.
2
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.血清白细胞介素-6 水平升高可识别出肝硬化患者中肝性脑病高风险人群。
Aliment Pharmacol Ther. 2019 Nov;50(10):1112-1119. doi: 10.1111/apt.15515. Epub 2019 Oct 3.
3
Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.肝硬化患者不同神经精神异常的不同生化相关性。
Hepatology. 2011 Feb;53(2):558-66. doi: 10.1002/hep.24043. Epub 2011 Jan 3.
4
Ammonia levels and the severity of hepatic encephalopathy.氨水平与肝性脑病的严重程度。
J Coll Physicians Surg Pak. 2014 Mar;24(3):160-3.
5
Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.肝硬变患者肝性脑病的二级预防:L-鸟氨酸-L-天冬氨酸与安慰剂的双盲随机对照试验
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):951-958. doi: 10.1097/MEG.0000000000001137.
6
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.谷氨酰胺负荷后毛细血管血氨床边检测改善肝硬化肝性脑病的诊断。
BMC Gastroenterol. 2011 Dec 8;11:134. doi: 10.1186/1471-230X-11-134.
7
Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy.使用S100β作为肝性脑病标志物的临床情况。
World J Gastroenterol. 2016 May 7;22(17):4397-402. doi: 10.3748/wjg.v22.i17.4397.
8
Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.益生菌治疗对轻微肝性脑病肝硬化患者的影响:一项荟萃分析。
Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):9-16. doi: 10.1016/j.hbpd.2018.01.005. Epub 2018 Feb 2.
9
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.低钠血症是肝硬化患者发生肝性脑病的一个危险因素:一项采用时间依赖性分析的前瞻性研究。
Am J Gastroenterol. 2009 Jun;104(6):1382-9. doi: 10.1038/ajg.2009.293.
10
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.L-鸟氨酸-L-天冬氨酸输注对肝硬化和肝性脑病患者的治疗效果:一项安慰剂对照双盲研究的结果
Hepatology. 1997 Jun;25(6):1351-60. doi: 10.1002/hep.510250609.

引用本文的文献

1
A Machine Learning-Based Prognostication Model Enhances Prediction of Early Hepatic Encephalopathy in Patients With Noncancer-Related Cirrhosis: Multicenter Longitudinal Cohort Study in Taiwan.基于机器学习的预后模型可增强对非癌性肝硬化患者早期肝性脑病的预测:台湾多中心纵向队列研究
JMIR Med Inform. 2025 Aug 6;13:e71229. doi: 10.2196/71229.
2
Correlation of ammonia and blood laboratory parameters with hepatic encephalopathy: A systematic review and meta-analysis.氨与血液实验室参数与肝性脑病的相关性:系统评价和荟萃分析。
PLoS One. 2024 Sep 3;19(9):e0307899. doi: 10.1371/journal.pone.0307899. eCollection 2024.
3
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.

本文引用的文献

1
Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.炎症:肝硬化肝性脑病当前治疗的新靶点。
World J Gastroenterol. 2015 Nov 7;21(41):11815-24. doi: 10.3748/wjg.v21.i41.11815.
2
Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia.肝性脑病的病理生理学与管理2014年更新:氨中毒与低钠血症
Hepatol Res. 2015 Dec;45(12):1155-62. doi: 10.1111/hepr.12495. Epub 2015 Mar 2.
3
Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.
利福昔明治疗日本患者隐匿性肝性脑病和高血氨的疗效。
PLoS One. 2022 Jul 1;17(7):e0270786. doi: 10.1371/journal.pone.0270786. eCollection 2022.
4
Update on blood-based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience.慢性肝病预后的血液生物标志物最新进展:文献综述与机构经验
JGH Open. 2021 Oct 30;5(11):1250-1256. doi: 10.1002/jgh3.12667. eCollection 2021 Nov.
5
Prediction of minimal hepatic encephalopathy by using an radiomics nomogram in chronic hepatic schistosomiasis patients.利用放射组学列线图预测慢性血吸虫病患者的轻微肝性脑病。
PLoS Negl Trop Dis. 2021 Oct 15;15(10):e0009834. doi: 10.1371/journal.pntd.0009834. eCollection 2021 Oct.
6
Chinese guidelines on management of hepatic encephalopathy in cirrhosis.《肝硬化肝性脑病诊治指南》
World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403.
7
Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. covert 型肝性脑病自然史:366 例肝硬化患者的观察性研究。
World J Gastroenterol. 2017 Sep 14;23(34):6321-6329. doi: 10.3748/wjg.v23.i34.6321.
8
Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.肝硬化患者的水、电解质、酸碱和微量元素改变。
Int Urol Nephrol. 2018 Jan;50(1):81-89. doi: 10.1007/s11255-017-1614-y. Epub 2017 Jun 12.
9
Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy.高氨血症与肝硬化和肝性脑病的严重程度增加相关。
Int J Hepatol. 2016;2016:6741754. doi: 10.1155/2016/6741754. Epub 2016 Oct 25.
益生菌 VSL#3 可降低肝硬化患者的肝脏疾病严重程度和住院率:一项随机对照试验。
Gastroenterology. 2014 Dec;147(6):1327-37.e3. doi: 10.1053/j.gastro.2014.08.031. Epub 2014 Aug 27.
4
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.肝硬化急性失代偿和慢加急性肝衰竭患者的肝性脑病。
J Hepatol. 2015 Feb;62(2):437-47. doi: 10.1016/j.jhep.2014.09.005. Epub 2014 Sep 10.
5
Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.低钠血症的纠正可改善肝硬化患者的认知、生活质量和脑水肿。
J Hepatol. 2015 Jan;62(1):75-82. doi: 10.1016/j.jhep.2014.07.033. Epub 2014 Aug 8.
6
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病:美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
7
Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life.
Ann Hepatol. 2014 May-Jun;13(3):407-8.
8
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.血清内毒素、炎症介质与轻微型肝性脑病患者治疗前后的磁共振波谱分析
J Gastroenterol Hepatol. 2013 Jul;28(7):1187-93. doi: 10.1111/jgh.12160.
9
Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.与肝硬化腹水患者生活质量相关的因素:血清钠浓度和腿部水肿的相关性。
J Hepatol. 2012 Dec;57(6):1199-206. doi: 10.1016/j.jhep.2012.07.020. Epub 2012 Jul 20.
10
Covert hepatic encephalopathy: not as minimal as you might think.隐匿性肝性脑病:并非如你想象的那么轻微。
Clin Gastroenterol Hepatol. 2012 Nov;10(11):1208-19. doi: 10.1016/j.cgh.2012.05.026. Epub 2012 Jun 19.